|
Volumn 25, Issue 5, 2004, Pages 493-501
|
The utility of partial cross-over designs in early phase randomized prevention trials
|
Author keywords
Clinical trial design; Cross over design; Parallel design; Phase II study
|
Indexed keywords
BIOLOGICAL MARKER;
DICHLOROACETIC ACID;
PLACEBO;
SELENIUM;
SELENOMETHIONINE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COMPUTER ANALYSIS;
COMPUTER PROGRAM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SCREENING;
EXPERIMENT;
EXPERIMENTAL MODEL;
HUMAN;
LACTIC ACIDOSIS;
LUNG CARCINOGENESIS;
MEDICAL INFORMATION;
METHODOLOGY;
OUTCOMES RESEARCH;
PATIENT;
PROPHYLAXIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
SAMPLE SIZE;
SCORING SYSTEM;
SURVIVAL;
CLINICAL TRIALS, PHASE II;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 4644298463
PISSN: 01972456
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cct.2004.07.005 Document Type: Article |
Times cited : (11)
|
References (5)
|